U.S. Leisure Stock News

NYSE:NYT
NYSE:NYTMedia

A Look At New York Times (NYT) Valuation After Recent Share Price Pullback

Recent stock performance and context Without a specific headline event driving attention, New York Times (NYT) still gives you some numbers to consider, with the stock’s 1 day move at about a 4.2% decline and mixed recent returns. See our latest analysis for New York Times. That 4.2% one day drop sits against a 17.7% 90 day share price return and a 54.2% 1 year total shareholder return. This suggests that recent momentum has cooled after a strong run. If this kind of move has you thinking...
NYSE:VICI
NYSE:VICISpecialized REITs

VICI’s Raised AFFO Outlook and Casino Deals Could Be A Game Changer For VICI Properties (VICI)

VICI Properties Inc. reported first-quarter 2026 results with revenue of US$1.02 billion, net income of US$872.39 million, and basic earnings per share of US$0.82, while also lifting full-year AFFO guidance. Alongside these earnings, VICI accelerated portfolio expansion by acquiring Golden Entertainment’s seven Nevada casino real estate assets and the Deerfoot Inn & Casino, and committing about US$1.5 billion to mezzanine lending. We’ll now examine how VICI’s raised AFFO outlook and...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

Is Astec Industries (ASTE) Still Fairly Priced After Recent Share Price Pullback?

If you are wondering whether Astec Industries at around US$53 is still sensibly priced or starting to look stretched, you are not alone. The stock has seen an 18.5% decline over the last 7 days and a 4.3% decline over the last 30 days, yet it is still up 18.8% year to date and 36.6% over the past 12 months. This can change how you think about both risk and opportunity. Recent news coverage has focused on how Astec Industries is positioned within the broader capital goods sector and how its...
NYSE:CTVA
NYSE:CTVAChemicals

Corteva’s Vylor Spinoff And Bayer Deal Reframe Valuation Story

Corteva (NYSE:CTVA) has branded its upcoming seed and genetics spinoff as Vylor, marking a key step toward separating into two focused agricultural companies. The company has also finalized a comprehensive litigation settlement with Bayer, which includes expanded licensing opportunities tied to Corteva's technology portfolio. The settlement and new branding move come as Corteva continues to reshape its business around distinct seed and crop protection platforms. Corteva's recent moves...
NYSE:MKL
NYSE:MKLInsurance

Is It Time To Reassess Markel Group (MKL) After This Year’s Share Price Pullback?

Wondering if Markel Group at around US$1,799.97 is offering fair value right now, or if the price is out of line with what you are actually getting. The stock has returned 1.6% over the last week, while the 30 day return is a 5.5% decline and the year to date return is a 15.5% decline, with a 1 year return of 4.3% decline and longer term 3 year and 5 year returns of 31.0% and 48.5% respectively. Recent coverage has focused on Markel Group's position in the insurance space and how the stock's...
NYSE:OSCR
NYSE:OSCRInsurance

Why Oscar Health (OSCR) Is Up 13.1% After Record Q1 Profit Surge And Membership Growth

In the past week, Oscar Health, Inc. reported first-quarter 2026 results showing revenue of US$4.65 billion and net income of US$679.00 million, with diluted EPS from continuing operations of US$2.07, all sharply higher than a year earlier. The quarter also brought record profitability supported by a more than 50% membership increase and improved medical loss and operating margin metrics, while management reaffirmed full-year 2026 guidance and highlighted new initiatives such as the Lucie...
NasdaqGS:LIN
NasdaqGS:LINChemicals

Is It Time To Reassess Linde (LIN) After Its Strong Year To Date Performance

If you are wondering whether Linde at around US$493.85 is offering fair value or asking too much, the next sections will help you put a clear number on what you are really paying for the stock. The share price has been relatively steady recently, with a 1.5% decline over the last 7 days and a 0.1% decline over 30 days, while still showing a 15.1% return year to date and 10.4% over the past year. Recent news coverage has largely focused on Linde's position as a global industrial gases company...
NYSE:EPR
NYSE:EPRSpecialized REITs

EPR Properties (EPR) Q1 2026 Earnings Margin Surge Tests Bullish Narratives

EPR Properties (EPR) opened Q1 2026 with total revenue of US$181.3 million and basic EPS of US$0.74, while trailing twelve month figures show revenue of US$720.2 million and basic EPS of US$3.25 as earnings almost doubled year over year by 98.1%. Over the past year, revenue has moved from US$688.3 million to US$720.2 million and net income shifted from US$121.9 million to US$247.6 million, lifting the reported net profit margin from 17.9% to 34.4% on a trailing basis. Together, the latest...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Is It Time To Reassess Amazon.com (AMZN) After Its Strong Share Price Rally?

If you have ever wondered whether Amazon.com at US$271.17 is priced for its future potential or already reflects a lot of optimism, this article is for you. The stock has returned 2.3% over the last 7 days, 26.9% over the last 30 days, 19.7% year to date and 41.2% over the last year, with a 3 year return of 141.7% and 5 year return of 71.5%. Recent headlines have continued to focus on Amazon.com's scale in e-commerce and cloud infrastructure, as well as its ongoing investments in logistics...
NYSE:COF
NYSE:COFConsumer Finance

Is Capital One Financial (COF) Pricing Reflect Recent Stock Volatility And Credit Cycle Uncertainty

If you are wondering whether Capital One Financial at around US$192.59 is offering value or asking you to pay up for growth, this article breaks down what the current price implies. The stock has returned 0.7% over the last week and 6.3% over the last month, while year to date it is down 22.3%. It currently has a 1 year return of 3.0% and a 3 year return of 131.8%, compared with 34.9% over 5 years. Recent coverage has focused on Capital One Financial's position in consumer finance and...
NYSE:RDDT
NYSE:RDDTInteractive Media and Services

Reddit (RDDT) Is Up 11.4% After Q1 Profit Surge On Ads And AI Data Deals - Has The Bull Case Changed?

In the first quarter of 2026, Reddit, Inc. reported sales of US$663.41 million and net income of US$203.98 million, with basic earnings per share from continuing operations of US$1.07, all sharply higher than a year earlier. Beyond strong ad growth, Reddit’s expanding high-margin data licensing business, supported by multi-year AI training deals, is increasingly shaping its profit profile. We’ll now examine how Reddit’s strong Q1 revenue and profit jump, powered by advertising and data...
NYSE:RDW
NYSE:RDWAerospace & Defense

Redwire (RDW) Q1 2026 Heavy US$78 Million Loss Reinforces Bearish Profitability Concerns

Redwire (RDW) opened Q1 2026 with total revenue of US$97.0 million and a basic EPS loss of US$0.40, alongside trailing twelve month revenue of US$371.0 million and a basic EPS loss of US$2.29. Looking back over recent quarters, the company reported quarterly revenue of US$61.4 million in Q1 2025, US$61.8 million in Q2, US$103.4 million in Q3 and US$108.8 million in Q4. Over the same period, basic EPS losses moved from US$0.09 to US$1.41, US$0.29 and US$0.57 respectively. This frames a Q1 2026...
NYSE:GRMN
NYSE:GRMNConsumer Durables

Is It Too Late To Consider Buying Garmin (GRMN) After A 95% Five Year Run?

If you are wondering whether Garmin's current share price reflects its underlying value, the recent track record gives plenty to think about. The stock last closed at US$241.90, with returns of 29.1% over 1 year, 19.5% year to date, 0.3% over 30 days, and a 3.7% decline over the past week, adding some short term volatility to a much longer run up of 95.0% over 5 years. These moves sit against a backdrop where investors have been closely watching Garmin's positioning across its product...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Did Strong Early PAPZIMEOS Revenue Guidance Just Shift Precigen's (PGEN) Investment Narrative?

Precigen recently announced it will release its first quarter 2026 financial results and business updates on May 13, 2026, alongside a conference call, with management indicating that PAPZIMEOS revenue for the period is expected to exceed US$18,000,000. This update highlights how the company’s shift to a commercial rare disease platform, anchored by PAPZIMEOS for recurrent respiratory papillomatosis, is starting to show through in early revenue traction despite ongoing reimbursement...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Immunocore (IMCR) Returns To Quarterly Profit And Tests Bearish Profitability Narratives

Immunocore Holdings (IMCR) opened 2026 with Q1 revenue of US$106.7 million and basic EPS of US$0.26, against a trailing twelve month revenue base of US$412.8 million and a basic EPS loss of US$0.55. Over recent quarters the company has reported revenue of US$84.1 million in Q4 2024, US$93.9 million in Q1 2025, US$98.0 million in Q2 2025, US$103.7 million in Q3 2025, US$104.5 million in Q4 2025 and US$106.7 million in Q1 2026. Over the same period, basic EPS has ranged from a loss of US$0.47...
NYSE:GEO
NYSE:GEOCommercial Services

Is GEO Group (GEO) Pricing Fair After Recent Share Price Rebound?

If you are trying to figure out whether GEO Group is attractively priced or looking stretched, the recent share performance raises some timely valuation questions. The stock closed at US$21.22, with returns of 14.6% over 7 days, 20.6% over 30 days, 33.2% year to date and a 19.3% decline over the last year, while the 3 year and 5 year returns stand at 139.0% and 244.5% respectively. Recent coverage around GEO Group has focused on how its share price path and sector role feed into debates...
NYSE:AIZ
NYSE:AIZInsurance

Is It Too Late To Consider Assurant (AIZ) After Its Strong Three Year Run?

Investors may be wondering if Assurant at about US$233.80 is still offering value after a strong run, or if they would now be paying up for the story. The stock has been relatively steady over the short term, with a 1% decline over the last week, a 6.9% gain over the last month, and returns of 21.9% over 1 year and 90.1% over 3 years. Recent attention on the stock has focused on how the business is positioned within the insurance sector and how investors are weighing its risk profile against...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

A Look At Power Solutions International (PSIX) Valuation As Class Action Lawsuits And Operational Strains Emerge

Why Power Solutions International is in the spotlight Power Solutions International (PSIX) is facing multiple securities class action lawsuits after disclosing operational inefficiencies, declining gross margins, and slower sales growth linked to its data center product ramp up. See our latest analysis for Power Solutions International. The legal headlines have coincided with a 15.2% 1 month share price return and a 17.0% year to date share price return, while the 1 year total shareholder...
NYSE:QSR
NYSE:QSRHospitality

Restaurant Brands International (QSR) Q1 EPS Surge Reinforces Margin Focus Narrative

Restaurant Brands International (NYSE:QSR) opened 2026 with Q1 revenue of US$2.3 billion and basic EPS of US$0.97, supported by net income from ongoing operations of US$338 million. The company reported an increase in quarterly revenue from US$2.1 billion in Q1 2025 to US$2.3 billion in Q1 2026, while basic EPS over the same period moved from US$0.49 to US$0.97. The latest quarter sits alongside trailing twelve month EPS of US$3.23. Taken together with 3.2% same restaurant sales growth, these...